questions for p.c, page-16

Lakey - please ask PC
- what accountability does he have for the languishing share price?
- why does a glass half-empty permeate through most announcements?
- why is he a point of contact for Public Relations & Marketing?
- why does he never question GSK, and if he does, why aren't shareholders aware of any efforts Biota might make to understand the poor performance of Relenza in Europe?
- why does he provide very limited and infrequent updates to shareholders?
- Is he embarrassed collecting a very healthy salary while Biota shareholders lose money everyday?